Oxycodone HCL-Acetaminophen Tablets
This federal contract opportunity has been awarded to on September 29, 2022.
Award Information
DEPT OF DEFENSE awarded this contract to for $7,299,520 on September 29, 2022, as part of federal procurement initiatives.
This award is part of federal acquisition procurement activities.
- Award Number
- SPE2D222D0150
- Award Amount
- $7,299,520
- Award Date
- September 29, 2022
Key Takeaways
- No response deadline specified - contact the agency for details
- Full and open competition - all businesses eligible to bid
- Work to be performed in PHILADELPHIA, PA
- Industry: Pharmaceutical and Medicine Manufacturing
Contract Details
- Notice ID
- SPE2D221R0114
- Opportunity Type
- Award Notice
- Agency
- DEPT OF DEFENSE
- Sub-Agency
- DEFENSE LOGISTICS AGENCY
- Office
- DLA TROOP SUPPORT
- Posted Date
- Tuesday, September 2, 2025
- Response Deadline
- Not specified
- PSC Code
- 6505
- Set-Aside
- Full & Open Competition
- Place of Performance
- PHILADELPHIA, PA, 19111
- Status
- Active
Description
SPE2D2-22-D-0150 P00007 to invoke Option Year 3 SPE2D2-22-D-0150 P00006 Mass Modification based on Executive Orders. SPE2D2-22-D-0150 P00005 to invoke Option Year 2 SPE2D2-22-D-0150 P00003 to invoke Option Year 1 SPE2D2-22-D-0150 P00002 To incorporate Drug Supply Chanin Act (DCSA) language into solicitation for subject contract. SPE2D2-22-D-0150 P00001 To incorporate FAR 52.204-27 Prohibtion on a Bytedance Covered Application (June 2023) into subject contract. Oxycodone HCL/Acetaminophen Tablets contract award SPE2D2-22-D-0150 Line Items 0001 through 0005.
Why This Opportunity Matters
The Department of DEFENSE is seeking responses for pharmaceutical and medicine manufacturing in PHILADELPHIA, PA.
Browse Related
Looking for more opportunities?
Browse our full directory of government contracts
